591 related articles for article (PubMed ID: 32751847)
21. Photoreactive Hydrogel Stiffness Influences Volumetric Muscle Loss Repair.
Basurto IM; Passipieri JA; Gardner GM; Smith KK; Amacher AR; Hansrisuk AI; Christ GJ; Caliari SR
Tissue Eng Part A; 2022 Apr; 28(7-8):312-329. PubMed ID: 34409861
[TBL] [Abstract][Full Text] [Related]
22. Scalable macroporous hydrogels enhance stem cell treatment of volumetric muscle loss.
Eugenis I; Wu D; Hu C; Chiang G; Huang NF; Rando TA
Biomaterials; 2022 Nov; 290():121818. PubMed ID: 36209578
[TBL] [Abstract][Full Text] [Related]
23. Immunomodulation and Biomaterials: Key Players to Repair Volumetric Muscle Loss.
Kiran S; Dwivedi P; Kumar V; Price RL; Singh UP
Cells; 2021 Aug; 10(8):. PubMed ID: 34440785
[TBL] [Abstract][Full Text] [Related]
24. Engineering functional and histological regeneration of vascularized skeletal muscle.
Gilbert-Honick J; Iyer SR; Somers SM; Lovering RM; Wagner K; Mao HQ; Grayson WL
Biomaterials; 2018 May; 164():70-79. PubMed ID: 29499437
[TBL] [Abstract][Full Text] [Related]
25. A tissue engineering approach for repairing craniofacial volumetric muscle loss in a sheep following a 2, 4, and 6-month recovery.
Rodriguez BL; Vega-Soto EE; Kennedy CS; Nguyen MH; Cederna PS; Larkin LM
PLoS One; 2020; 15(9):e0239152. PubMed ID: 32956427
[TBL] [Abstract][Full Text] [Related]
26.
Li MT; Ruehle MA; Stevens HY; Servies N; Willett NJ; Karthikeyakannan S; Warren GL; Guldberg RE; Krishnan L
Tissue Eng Part A; 2017 Sep; 23(17-18):989-1000. PubMed ID: 28372522
[TBL] [Abstract][Full Text] [Related]
27. Regenerative medicine for skeletal muscle loss: a review of current tissue engineering approaches.
Langridge B; Griffin M; Butler PE
J Mater Sci Mater Med; 2021 Jan; 32(1):15. PubMed ID: 33475855
[TBL] [Abstract][Full Text] [Related]
28. Repairing Volumetric Muscle Loss in the Ovine Peroneus Tertius Following a 6-Month Recovery.
Rodriguez BL; Novakova SS; Vega-Soto EE; Nutter GP; Macpherson PCD; Larkin LM
Tissue Eng Part A; 2022 Jul; 28(13-14):606-620. PubMed ID: 34937425
[TBL] [Abstract][Full Text] [Related]
29. Pharmaceutical Agents for Contractile-Metabolic Dysfunction After Volumetric Muscle Loss.
McFaline-Figueroa J; Schifino AG; Nichenko AS; Lord MN; Hunda ET; Winders EA; Noble EE; Greising SM; Call JA
Tissue Eng Part A; 2022 Sep; 28(17-18):795-806. PubMed ID: 35620911
[TBL] [Abstract][Full Text] [Related]
30. Stem Cells for Skeletal Muscle Tissue Engineering.
Pantelic MN; Larkin LM
Tissue Eng Part B Rev; 2018 Oct; 24(5):373-391. PubMed ID: 29652595
[TBL] [Abstract][Full Text] [Related]
31. Agent-based model provides insight into the mechanisms behind failed regeneration following volumetric muscle loss injury.
Westman AM; Peirce SM; Christ GJ; Blemker SS
PLoS Comput Biol; 2021 May; 17(5):e1008937. PubMed ID: 33970905
[TBL] [Abstract][Full Text] [Related]
32. Laminin-111-Enriched Fibrin Hydrogels Enhance Functional Muscle Regeneration Following Trauma.
Ziemkiewicz N; Hilliard GM; Dunn AJ; Madsen J; Haas G; Au J; Genovese PC; Chauvin HM; West C; Paoli A; Garg K
Tissue Eng Part A; 2022 Apr; 28(7-8):297-311. PubMed ID: 34409846
[TBL] [Abstract][Full Text] [Related]
33. Aligned Collagen Sponges with Tunable Pore Size for Skeletal Muscle Tissue Regeneration.
Kozan NG; Caswell S; Patel M; Grasman JM
J Funct Biomater; 2023 Oct; 14(11):. PubMed ID: 37998102
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of adipose-derived stem cells for tissue-engineered muscle repair construct-mediated repair of a murine model of volumetric muscle loss injury.
Kesireddy V
Int J Nanomedicine; 2016; 11():1461-73. PubMed ID: 27114706
[TBL] [Abstract][Full Text] [Related]
35. Cell and Growth Factor-Loaded Keratin Hydrogels for Treatment of Volumetric Muscle Loss in a Mouse Model.
Baker HB; Passipieri JA; Siriwardane M; Ellenburg MD; Vadhavkar M; Bergman CR; Saul JM; Tomblyn S; Burnett L; Christ GJ
Tissue Eng Part A; 2017 Jun; 23(11-12):572-584. PubMed ID: 28162053
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in implantable biomaterials for the treatment of volumetric muscle loss.
Schiltz L; Grivetti E; Tanner GI; Qazi TH
Cells Tissues Organs; 2024 Jan; ():. PubMed ID: 38219727
[TBL] [Abstract][Full Text] [Related]
37. Biomimetic glycosaminoglycan-based scaffolds improve skeletal muscle regeneration in a Murine volumetric muscle loss model.
Narayanan N; Jia Z; Kim KH; Kuang L; Lengemann P; Shafer G; Bernal-Crespo V; Kuang S; Deng M
Bioact Mater; 2021 Apr; 6(4):1201-1213. PubMed ID: 33163701
[TBL] [Abstract][Full Text] [Related]
38. Further development of a tissue engineered muscle repair construct in vitro for enhanced functional recovery following implantation in vivo in a murine model of volumetric muscle loss injury.
Corona BT; Machingal MA; Criswell T; Vadhavkar M; Dannahower AC; Bergman C; Zhao W; Christ GJ
Tissue Eng Part A; 2012 Jun; 18(11-12):1213-28. PubMed ID: 22439962
[TBL] [Abstract][Full Text] [Related]
39. Autologous minced muscle grafts: a tissue engineering therapy for the volumetric loss of skeletal muscle.
Corona BT; Garg K; Ward CL; McDaniel JS; Walters TJ; Rathbone CR
Am J Physiol Cell Physiol; 2013 Oct; 305(7):C761-75. PubMed ID: 23885064
[TBL] [Abstract][Full Text] [Related]
40. Codelivery of Infusion Decellularized Skeletal Muscle with Minced Muscle Autografts Improved Recovery from Volumetric Muscle Loss Injury in a Rat Model.
Kasukonis B; Kim J; Brown L; Jones J; Ahmadi S; Washington T; Wolchok J
Tissue Eng Part A; 2016 Oct; 22(19-20):1151-1163. PubMed ID: 27570911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
